185750.KS
Chong Kun Dang Pharmaceutical Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 68,200.00
−1.59%Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- KRW 1.3K
- EPS estimate
- KRW 2.5K
- Revenue actual
- KRW 475.4B
- Revenue estimate
- KRW 475.3B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -48.8%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Jul 31, 2026